http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105646492-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-04 |
| filingDate | 2014-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105646492-B |
| titleOfInvention | Substituted xanthine class compound and its preparation method and application containing five yuan of heteroaromatics |
| abstract | The invention discloses the substituted xanthine class compounds and its preparation method and application for containing five yuan of heteroaromatics.Specifically, the present invention relates to the compound and its stereoisomer of formula (I), pharmaceutically acceptable salt, as used in the description.The invention further relates to the pharmaceutical compositions comprising the compounds of this invention, the compounds of this invention is preparing the purposes in the drug for treating and/or preventing to over-express the method for related disease or illness with DPP-IV hyperactivity or with DPP-IV, and the method using the compounds of this invention treatment related disease.The compounds of this invention has effective DPP-IV inhibitory activity. |
| priorityDate | 2014-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 332.